Market Overview:
The global raubasine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. Raubasine is a drug used for the treatment of hypertension and other cardiovascular diseases. It is available in the form of injection, tablet, and other forms. The global raubasine market is segmented on the basis of type, application, and region. On the basis of type, it is segmented into injection, tablet, and other forms. Injection accounted for a major share in 2017 owing to its high demand in hospitals and clinics across the globe. Tablet form held second largest share in 2017 due to its easy availability over-the-counter (OTC) without prescription in many countries worldwide.
Product Definition:
Raubasine is a purine analogue that inhibits inosine monophosphate dehydrogenase, and has antileukemic and immunosuppressive activities.
Injection:
Injection is a growth factor present in Raubasine. It helps the cells to multiply and grow rapidly. The injection also has some side effects like it can damage the DNA of cells, cause cancer or even death of certain types of cells.
The global market for Injection is expected to witness significant growth over the forecast period owing to its increasing usage in arthritis treatment.
Tablet:
Tablet is a portable computer device that contains a display, input devices and speakers. It has an advanced operating system which makes it capable of performing any task assigned to it. The tablet can be used for entertainment as well as work purposes. It has the ability to connect to the internet and can access any information from anywhere across the globe through wireless connection.
Application Insights:
The other application segment dominated the global raubasine market in 2017, accounting for over 60% share of the total revenue. The anti-hypertensive drug is expected to be one of the major applications of this compound. Raubasine has been used as an effective anti- hypertension agent owing to its ability to reduce blood pressure by increasing peripheral resistance and reducing blood cholesterol levels.
In addition, it also acts as a nitric oxide donor which enhances endothelial function and reduces vascular reactivity thereby lowering BP levels. Several pharmaceutical companies are currently researching on new ways to use raubaoline for treating hypertension which may result in higher demand during the forecast period.
Other key applications include diabetes mellitus type 2.
Regional Analysis:
North America dominated the global raubasine market in 2017. The region is expected to maintain its position through the forecast period on account of increasing healthcare expenditure and prevalence of hypertension coupled with awareness campaigns regarding product usage. In addition, presence of major players in this region will also help maintain dominance over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to rising disposable income, improving healthcare infrastructure and growing target population base especially in India & China & Japan etc. Increasing demand for generic drugs due to patent expirations or regulatory changes by regulatory authorities such as FDA will drive this regional market further.
Growth Factors:
- Increasing demand for Raubasine in the pharmaceutical and nutraceutical industries as a natural product for various applications such as anti-inflammatory, analgesic, anticancer, and antioxidant properties.
- Growing research on Raubasine for its potential therapeutic benefits in different diseases is expected to fuel the market growth.
- Rising awareness about the health benefits of Raubasine is projected to boost the demand over the forecast period.
- Technological advancements in extraction and purification processes are likely to provide new opportunities for market growth.
Scope Of The Report
Report Attributes
Report Details
Report Title
Raubasine Market Research Report
By Type
Injection, Tablet, Other
By Application
Anti Hypertensive, Other
By Companies
Sarv Bio Labs, Enrich Pharma, Tangerine Bio, Sheeji Pharma International
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Raubasine Market Report Segments:
The global Raubasine market is segmented on the basis of:
Types
Injection, Tablet, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Anti Hypertensive, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sarv Bio Labs
- Enrich Pharma
- Tangerine Bio
- Sheeji Pharma International
Highlights of The Raubasine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injection
- Tablet
- Other
- By Application:
- Anti Hypertensive
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Raubasine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Raubasine is a natural extract from the bark of the rauwolfia serpentina tree. It has been used in traditional medicine to treat a variety of conditions, including anxiety, depression, and stress.
Some of the major players in the raubasine market are Sarv Bio Labs, Enrich Pharma, Tangerine Bio, Sheeji Pharma International.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Raubasine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Raubasine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Raubasine Market - Supply Chain
4.5. Global Raubasine Market Forecast
4.5.1. Raubasine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Raubasine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Raubasine Market Absolute $ Opportunity
5. Global Raubasine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Raubasine Market Size and Volume Forecast by Type
5.3.1. Injection
5.3.2. Tablet
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Raubasine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Raubasine Market Size and Volume Forecast by Application
6.3.1. Anti Hypertensive
6.3.2. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Raubasine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Raubasine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Raubasine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Raubasine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Raubasine Demand Share Forecast, 2019-2026
9. North America Raubasine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Raubasine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Raubasine Market Size and Volume Forecast by Application
9.4.1. Anti Hypertensive
9.4.2. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Raubasine Market Size and Volume Forecast by Type
9.7.1. Injection
9.7.2. Tablet
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Raubasine Demand Share Forecast, 2019-2026
10. Latin America Raubasine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Raubasine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Raubasine Market Size and Volume Forecast by Application
10.4.1. Anti Hypertensive
10.4.2. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Raubasine Market Size and Volume Forecast by Type
10.7.1. Injection
10.7.2. Tablet
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Raubasine Demand Share Forecast, 2019-2026
11. Europe Raubasine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Raubasine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Raubasine Market Size and Volume Forecast by Application
11.4.1. Anti Hypertensive
11.4.2. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Raubasine Market Size and Volume Forecast by Type
11.7.1. Injection
11.7.2. Tablet
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Raubasine Demand Share, 2019-2026
12. Asia Pacific Raubasine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Raubasine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Raubasine Market Size and Volume Forecast by Application
12.4.1. Anti Hypertensive
12.4.2. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Raubasine Market Size and Volume Forecast by Type
12.7.1. Injection
12.7.2. Tablet
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Raubasine Demand Share, 2019-2026
13. Middle East & Africa Raubasine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Raubasine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Raubasine Market Size and Volume Forecast by Application
13.4.1. Anti Hypertensive
13.4.2. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Raubasine Market Size and Volume Forecast by Type
13.7.1. Injection
13.7.2. Tablet
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Raubasine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Raubasine Market: Market Share Analysis
14.2. Raubasine Distributors and Customers
14.3. Raubasine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Sarv Bio Labs
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Enrich Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Tangerine Bio
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Sheeji Pharma International
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
